Decheng Capital China Life Sciences USD Fund III, L.P. sold BYSI
July 2, 2025 · Form 4 insider transaction
Decheng Capital China Life Sciences USD Fund III, L.P. sold 324 shares of BeyondSpring Inc. at $2.42 per share, a transaction worth $784.08. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 40 days after the transaction.
Footnotes
These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.